MAPT and early-onset autosomal dominant Alzheimer disease: In addition, during hyperglycemia, tau protein and amyloid β are nonenzymatically glycosylated to form glycosylation end products (AGEs), which are known to participate in the pathological manifestations of Alzheimer's disease.